当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析 - 现金流量表

微芯生物

(688321)

  

流通市值:127.73亿  总市值:138.73亿
流通股本:4.08亿   总股本:4.43亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金268,618,755.61837,530,470.82600,839,571.42398,607,546.28
  收到其他与经营活动有关的现金1,434,238.1840,669,807.5436,992,053.5134,576,857.56
  经营活动现金流入小计270,052,993.79878,200,278.36637,831,624.93433,184,403.84
  购买商品、接受劳务支付的现金15,453,080.3467,762,633.2648,540,672.8730,769,935.76
  支付给职工以及为职工支付的现金102,931,064.51315,576,668.48246,368,451.96175,579,202.94
  支付的各项税费15,525,962.0347,429,193.8930,129,889.3715,218,658.25
  支付其他与经营活动有关的现金111,798,928.8350,466,424.44252,870,535.95149,558,109.37
  经营活动现金流出小计245,709,035.68781,234,920.07577,909,550.15371,125,906.32
  经营活动产生的现金流量净额24,343,958.1196,965,358.2959,922,074.7862,058,497.52
二、投资活动产生的现金流量:
  收回投资收到的现金305,681,247.631,648,646,830.261,101,320,011.15690,883,550.34
  取得投资收益收到的现金4,463,131.5118,839,001.29,530,779.855,148,176.9
  处置固定资产、无形资产和其他长期资产收回的现金净额16,363.9813,772.7813,772.789,640.05
  投资活动现金流入小计310,160,743.121,667,499,604.241,110,864,563.78696,041,367.29
  购建固定资产、无形资产和其他长期资产支付的现金100,502,759.4178,602,604.92114,938,351.1653,208,351.12
  投资支付的现金903,854,849.591,706,512,516.661,144,869,696.66692,756,636.68
  投资活动现金流出小计1,004,357,608.991,885,115,121.581,259,808,047.82745,964,987.8
  投资活动产生的现金流量净额-694,196,865.87-217,615,517.34-148,943,484.04-49,923,620.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金938,339,997.44---
  取得借款收到的现金110,524,000491,902,465401,885,265197,000,000
  筹资活动现金流入小计1,048,863,997.44491,902,465401,885,265197,000,000
  偿还债务支付的现金123,961,536.67310,941,816.68208,970,280.0187,398,743.34
  分配股利、利润或偿付利息支付的现金6,464,846.7131,742,274.0725,439,063.5612,686,146.86
  支付其他与筹资活动有关的现金5,220,035.0421,618,223.953,502,845.312,225,939.97
  筹资活动现金流出小计135,646,418.42364,302,314.7237,912,188.88102,310,830.17
  筹资活动产生的现金流量净额913,217,579.02127,600,150.3163,973,076.1294,689,169.83
四、汇率变动对现金及现金等价物的影响-788,180.1-807,474.93-1,729,409.36-77,413.06
五、现金及现金等价物净增加额242,576,491.166,142,516.3273,222,257.5106,746,633.78
  加:期初现金及现金等价物余额228,682,925.18222,540,408.86222,540,408.86222,540,408.86
  期末现金及现金等价物余额471,259,416.34228,682,925.18295,762,666.36329,287,042.64
补充资料:
  净利润-50,959,162.56-29,592,228.83
  固定资产和投资性房地产折旧-36,463,907.12-18,118,834.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,463,907.12-18,118,834.39
  无形资产摊销-31,287,590.47-15,490,652.34
  长期待摊费用摊销-2,840,932.43-1,514,295
  处置固定资产、无形资产和其他长期资产的损失---10,585.9
  固定资产报废损失-69,711.8-40,310.14
  公允价值变动损失--238,945.2--
  财务费用-22,789,141.43-9,683,864.89
  投资损失-25,076,401.36-10,753,345.71
  递延所得税--1,454,462.3--1,806,179.79
  其中:递延所得税资产减少--1,368,285.04-5,476.17
    递延所得税负债增加--86,177.26--1,811,655.96
  存货的减少--16,838,616.46--13,773,112.15
  经营性应收项目的减少--160,139,574.06--75,787,772.11
  经营性应付项目的增加-102,645,815.36-67,813,337.48
  其他--1,969,373.64--935,513.86
  现金的期末余额-228,682,925.18-329,287,042.64
  减:现金的期初余额-222,540,408.86-222,540,408.86
  现金及现金等价物的净增加额-6,142,516.32-106,746,633.78
公告日期2026-04-302026-03-312025-10-312025-08-26
审计意见(境内)标准无保留意见
TOP↑